Galena Biopharma (GALE) Files 9.47M Common Shelf for Shareholders
Tweet
Share
E-mailGet Alerts GALE Hot Sheet
Join SI Premium – FREE
Galena Biopharma (Nasdaq: GALE) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to 9,470,000 shares of Common Stock on behalf of Selling Shareholders.
Galena will not receive proceeds from the sales.
Galena will not receive proceeds from the sales.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karman Line Acquisition closes $200M IPO on Nasdaq
- CleanTech Vanadium plans $1M private placement at $0.10 per unit
- Werewolf Therapeutics to merge with Ambros in $150M private placement
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
